GSK-200599

Study Sponsor: GSK

Study Title

Extension to study MALARIA-055 PRI (NCT00866619) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’ candidate malaria vaccine (SB257049) in infants and children in Africa

Medicine or Vaccine (generic name)

RTS,S Vaccine

Sponsor Identification Number

200599

Trial Registry Identification Number(#'s)

NCT02207816

Medical Condition

Malaria

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=200599

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02207816

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is an extension study to 110021.

Date Added to this Site

September 2019